// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Fetal cardiac function in twin pregnancies complicated by selective fetal growth restriction according to the umbilical artery Doppler pattern

F. D'Antonio - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

*Pregnancy outcome following fetal reduction of trichorionic triamniotic triplets: a national Danish register-based study from 2008 to 2018

S.E. Kristensen - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

N/A

First in-human use of high-intensity focused ultrasound to occlude placental vessels non-invasively in TTTS

C.J. Shaw - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Twin–twin transfusion syndrome

N/A

Pregnancy outcome after fetal reduction of dichorionic triamniotic triplets: a national Danish register-based study from 2008 to 2018

S.E. Kristensen - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

N/A

*Pre-eclampsia screening in Denmark (PRESIDE): a national implementation study

I. Riishede - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Preeclampsia

Aspirin

Maternal hemodynamic function and angiogenic markers after COVID-19 infection in pregnancy

N. Schirwani - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Arterial stiffness

L-Tyrosine

Imaging characteristics of unicornuate uterus: an 11-year retrospective study

S. Murugesu - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Development of a statistical model from 3D ultrasound to describe growth of the fetal face with gestation

A.E. Clark - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Point-of-care ultrasound versus routine third trimester ultrasound and undiagnosed breech presentation

S. knights - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous preterm delivery

N/A

Success rate of the subcortical 3D fetal brain segmentation using deep learning algorithms

M. Aliasi - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Objective comparison of craniofacial features in FGR and normally grown fetuses using statistical shape modelling from 3D ultrasound

A.E. Clark - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Point-of-care ultrasound and undiagnosed breech presentation

S. knights - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous preterm delivery

N/A

Prediction of pre-eclampsia using machine learning

A. Khalil - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

22q11.2 deletion syndrome

N/A

Maternal cardiovascular profile in women with previous bariatric surgery

D. Patel - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Gestational Diabetes

N/A

Evaluating the impact of the availability of ultrasonography on the patient pathway in emergency gynecology

S. Murugesu - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Is one-step triage and M6 module safe in triaging pregnancy of unknown location?

H. Hadawi - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prognostic value of maternal serum angiogenic markers for prediction of maternal adverse outcomes in women with pre-eclampsia

J. Binder - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Preeclampsia

L-Tyrosine

Maternal cardiovascular profile in obese women compared to pregnant women with normal body mass index

D. Patel - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Placental growth factor is a predictive test for screening antenatal pre-eclampsia?

H. Hadawi - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Preeclampsia

N/A

Cost analysis of various choice of imaging in acute abdomen in pregnancy

F. Ajibade - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Fetal hydronephrosis

N/A

Copyright © 2026. QuantiNova All rights reserved